BBOTVSNIVF• 3 Months (Normalized)
BBOT vs NIVF (BridgeBio Oncology Therapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-53.75%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
NIVF Performance $0.13
-97.11%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+43.36 pts
BBOT outperforming by 43.36 percentage points
BBOTNIVF
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | BBOT Price | BBOT Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -53.75% | $0.13 | -97.11% | +43.36% |
| Oct 01, 2026 | $- | $0.10 | -97.74% | - | |
| Sep 30, 2026 | $4.10 | -51.25% | $0.17 | -96.24% | +44.99% |
| Sep 29, 2026 | $3.92 | -53.39% | $0.07 | -98.39% | +45.00% |
| Sep 28, 2026 | $3.81 | -54.70% | $0.35 | -92.28% | +37.58% |
| Sep 25, 2026 | $3.95 | -53.03% | $- | - | |
| Sep 24, 2026 | $3.99 | -52.56% | $- | - | |
| Sep 23, 2026 | $4.16 | -50.54% | $0.59 | -86.80% | +36.26% |
| Sep 22, 2026 | $4.66 | -44.59% | $0.73 | -83.59% | +39.00% |
| Sep 21, 2026 | $4.66 | -44.59% | $0.72 | -83.89% | +39.30% |
| Sep 18, 2026 | $4.77 | -43.28% | $0.72 | -83.91% | +40.63% |
| Sep 17, 2026 | $4.89 | -41.85% | $0.72 | -84.00% | +42.15% |
| Sep 16, 2026 | $4.76 | -43.40% | $0.79 | -82.44% | +39.04% |
| Sep 15, 2026 | $4.88 | -41.97% | $0.84 | -81.21% | +39.24% |
| Sep 14, 2026 | $5.05 | -39.95% | $0.93 | -79.22% | +39.27% |
Page 1 of 5